MLICM
BOLD

Metropolitan Life Insurance Company (MetLife)’s Audentes Therapeutics, Inc BOLD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,143
Closed -$846K – 2605
2019
Q4 		$846K Sell
14,143
-310
-2% -$11.6K 0.01% 993
2019
Q3 		$406K Buy
14,453
+1,603
+12% +$54.7K 0.01% 1422
2019
Q2 		$487K Buy
12,850
+294
+2% +$11.3K 0.01% 1324
2019
Q1 		$490K Hold
12,556
– – 0.01% 1313
2018
Q4 		$268K Buy
12,556
+1,971
+19% +$50.9K 0.01% 1616
2018
Q3 		$419K Hold
10,585
– – 0.01% 1493
2018
Q2 		$404K Buy
10,585
+4,877
+85% +$181K 0.01% 1463
2018
Q1 		$172K Hold
5,708
– – ﹤0.01% 1989
2017
Q4 		$178K Sell
5,708
-5,791
-50% -$159K ﹤0.01% 1982
2017
Q3 		$322K Hold
11,499
– – ﹤0.01% 1992
2017
Q2 		$220K Buy
+11,499
New +$184K ﹤0.01% 2281

Metropolitan Life Insurance Company (MetLife)'s BOLD Position: Q1 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 14,143 shares — an estimated $846K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BOLD in Q2 2017 and held it in 11 quarters. The position peaked at $846K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 14,143 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $846K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Audentes Therapeutics, Inc in Q2 2017 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Audentes Therapeutics, Inc position peaked at $846K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2020, filed 15 May 2020.